Literature DB >> 23467413

Minor modifications to the phosphate groups and the C3' acyl chain length of lipid A in two Bordetella pertussis strains, BP338 and 18-323, independently affect Toll-like receptor 4 protein activation.

Nita R Shah1, Sami Albitar-Nehme, Emma Kim, Nico Marr, Alexey Novikov, Martine Caroff, Rachel C Fernandez.   

Abstract

Lipopolysaccharides (LPS) of Bordetella pertussis are important modulators of the immune system. Interaction of the lipid A region of LPS with the Toll-like receptor 4 (TLR4) complex causes dimerization of TLR4 and activation of downstream nuclear factor κB (NFκB), which can lead to inflammation. We have previously shown that two strains of B. pertussis, BP338 (a Tohama I-derivative) and 18-323, display two differences in lipid A structure. 1) BP338 can modify the 1- and 4'-phosphates by the addition of glucosamine (GlcN), whereas 18-323 cannot, and 2) the C3' acyl chain in BP338 is 14 carbons long, but only 10 or 12 carbons long in 18-323. In addition, BP338 lipid A can activate TLR4 to a greater extent than 18-323 lipid A. Here we set out to determine the genetic reasons for the differences in these lipid A structures and the contribution of each structural difference to the ability of lipid A to activate TLR4. We show that three genes of the lipid A GlcN modification (Lgm) locus, lgmA, lgmB, and lgmC (previously locus tags BP0399-BP0397), are required for GlcN modification and a single amino acid difference in LpxA is responsible for the difference in C3' acyl chain length. Furthermore, by introducing lipid A-modifying genes into 18-323 to generate isogenic strains with varying penta-acyl lipid A structures, we determined that both modifications increase TLR4 activation, although the GlcN modification plays a dominant role. These results shed light on how TLR4 may interact with penta-acyl lipid A species.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23467413      PMCID: PMC3636864          DOI: 10.1074/jbc.M112.434365

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa.

Authors:  Umeharu Ohto; Koichi Fukase; Kensuke Miyake; Yoshinori Satow
Journal:  Science       Date:  2007-06-15       Impact factor: 47.728

2.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

3.  The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.

Authors:  Beom Seok Park; Dong Hyun Song; Ho Min Kim; Byong-Seok Choi; Hayyoung Lee; Jie-Oh Lee
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962

4.  Discovery of new biosynthetic pathways: the lipid A story.

Authors:  Christian R H Raetz; Ziqiang Guan; Brian O Ingram; David A Six; Feng Song; Xiaoyuan Wang; Jinshi Zhao
Journal:  J Lipid Res       Date:  2008-10-29       Impact factor: 5.922

5.  Substitution of the Bordetella pertussis lipid A phosphate groups with glucosamine is required for robust NF-kappaB activation and release of proinflammatory cytokines in cells expressing human but not murine Toll-like receptor 4-MD-2-CD14.

Authors:  Nico Marr; Adeline M Hajjar; Nita R Shah; Alexey Novikov; Cathy S Yam; Martine Caroff; Rachel C Fernandez
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

6.  Simple method for repurification of endotoxins for biological use.

Authors:  Alina Tirsoaga; Alexey Novikov; Minou Adib-Conquy; Catherine Werts; Catherine Fitting; Jean-Marc Cavaillon; Martine Caroff
Journal:  Appl Environ Microbiol       Date:  2007-01-19       Impact factor: 4.792

7.  Glucosamine found as a substituent of both phosphate groups in Bordetella lipid A backbones: role of a BvgAS-activated ArnT ortholog.

Authors:  Nico Marr; Alina Tirsoaga; Didier Blanot; Rachel Fernandez; Martine Caroff
Journal:  J Bacteriol       Date:  2008-04-18       Impact factor: 3.490

8.  Crystal structure of the YdjC-family protein TTHB029 from Thermus thermophilus HB8: structural relationship with peptidoglycan N-acetylglucosamine deacetylase.

Authors:  Takahito Imagawa; Hitoshi Iino; Mayumi Kanagawa; Akio Ebihara; Seiki Kuramitsu; Hideaki Tsuge
Journal:  Biochem Biophys Res Commun       Date:  2008-01-03       Impact factor: 3.575

9.  A rapid, small-scale procedure for the structural characterization of lipid A applied to Citrobacter and Bordetella strains: discovery of a new structural element.

Authors:  Alina Tirsoaga; Asmaa El Hamidi; Malcolm B Perry; Martine Caroff; Alexey Novikov
Journal:  J Lipid Res       Date:  2007-08-16       Impact factor: 5.922

10.  Structural basis for the acyl chain selectivity and mechanism of UDP-N-acetylglucosamine acyltransferase.

Authors:  Allison H Williams; Christian R H Raetz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-13       Impact factor: 11.205

View more
  17 in total

1.  Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces.

Authors:  Nina Maeshima; Tara Evans-Atkinson; Adeline M Hajjar; Rachel C Fernandez
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

2.  Bordetella pertussis naturally occurring isolates with altered lipooligosaccharide structure fail to fully mature human dendritic cells.

Authors:  Jolanda Brummelman; Rosanne E Veerman; Hendrik Jan Hamstra; Anna J M Deuss; Tim J Schuijt; Arjen Sloots; Betsy Kuipers; Cécile A C M van Els; Peter van der Ley; Frits R Mooi; Wanda G H Han; Elena Pinelli
Journal:  Infect Immun       Date:  2014-10-27       Impact factor: 3.441

3.  Substrate specificity of the pyrophosphohydrolase LpxH determines the asymmetry of Bordetella pertussis lipid A.

Authors:  Jesús Arenas; Elder Pupo; Eline de Jonge; Jesús Pérez-Ortega; Joerg Schaarschmidt; Peter van der Ley; Jan Tommassen
Journal:  J Biol Chem       Date:  2019-03-29       Impact factor: 5.157

4.  Bordetella pertussis lipid A glucosamine modification confers resistance to cationic antimicrobial peptides and increases resistance to outer membrane perturbation.

Authors:  Nita R Shah; Robert E W Hancock; Rachel C Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

Review 5.  Immunobiology and application of toll-like receptor 4 agonists to augment host resistance to infection.

Authors:  Antonio Hernandez; Naeem K Patil; Cody L Stothers; Liming Luan; Margaret A McBride; Allison M Owen; Katherine R Burelbach; David L Williams; Edward R Sherwood; Julia K Bohannon
Journal:  Pharmacol Res       Date:  2019-11-02       Impact factor: 7.658

6.  Structural and biological characteristics of different forms of V. filiformis lipid A: use of MS to highlight structural discrepancies.

Authors:  Aude Breton; Alexey Novikov; Richard Martin; Pierre Tissieres; Martine Caroff
Journal:  J Lipid Res       Date:  2017-01-25       Impact factor: 5.922

7.  Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission.

Authors:  Olivier Rolin; Sarah J Muse; Chetan Safi; Shokrollah Elahi; Volker Gerdts; Lauren E Hittle; Robert K Ernst; Eric T Harvill; Andrew Preston
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

8.  Reduction of endotoxicity in Bordetella bronchiseptica by lipid A engineering: Characterization of lpxL1 and pagP mutants.

Authors:  Jesús Pérez-Ortega; Roel M Van Harten; Ria Van Boxtel; Michel Plisnier; Marc Louckx; Dominique Ingels; Henk P Haagsman; Jan Tommassen
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

9.  Diet and specific microbial exposure trigger features of environmental enteropathy in a novel murine model.

Authors:  Eric M Brown; Marta Wlodarska; Benjamin P Willing; Pascale Vonaesch; Jun Han; Lisa A Reynolds; Marie-Claire Arrieta; Marco Uhrig; Roland Scholz; Oswaldo Partida; Christoph H Borchers; Philippe J Sansonetti; B Brett Finlay
Journal:  Nat Commun       Date:  2015-08-04       Impact factor: 14.919

Review 10.  Kdo2 -lipid A: structural diversity and impact on immunopharmacology.

Authors:  Xiaoyuan Wang; Peter J Quinn; Aixin Yan
Journal:  Biol Rev Camb Philos Soc       Date:  2014-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.